Breaking News

Apeloa Pharmaceutical Passes 20th FDA Inspection

Zhejiang Apeloa Tospo Pharmaceutical Co. Ltd., a subsidiary of Apeloa, passed the FDA inspection with No Action Indicated on October 24, 2025.

Author Image

By: Charlie Sternberg

Associate Editor

Apeloa Pharmaceutical, a global provider of technology-driven pharmaceutical manufacturing solutions, has successfully passed its 20th U.S. Food and Drug Administration (FDA) inspection, a milestone in the company’s history. Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd., a subsidiary of Apeloa that provides manufacturing services for Raw Starting Materials (RSMs), Intermediates, and Active Pharmaceutical Ingredients (APIs) for both clinical and commercial use, passed the FDA inspection with ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters